Patient centered outcomes

• PROs and other COAs

• Regulatory and HTA support

• Instrument development and selection

• Instrument testing and validation

• Interpretation of PRO and other COA data

Issues around PRO assessment to support drug development are explored in-depth in a publication co-authored by Annabel Nixon, published by SEEd 2015.

  Statistical consultancy services